XIAOJUN LIU

TitleAssistant Professor
InstitutionMD Anderson
DepartmentExperimental Therapeutics
Address1901 East Road
Houston TX 77054-3005
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Pitt WG, Perez KX, Tam NK, Handly E, Chinn JA, Liu XM, Maziarz EP. Quantitation of cholesterol and phospholipid sorption on silicone hydrogel contact lenses. J Biomed Mater Res Part B Appl Biomater. 2013 Nov; 101(8):1516-23. PMID: 23744756.
      Citations: 1     Translation:HumansCells
    2. Liu XJ, Nowak B, Wang YQ, Plunkett W. Sapacitabine, the prodrug of CNDAC, is a nucleoside analog with a unique action mechanism of inducing DNA strand breaks. Chin J Cancer. 2012 Aug; 31(8):373-80. PMID: 22739266.
      Citations: 8     Fields:    Translation:AnimalsCells
    3. Liu X, Kantarjian H, Plunkett W. Sapacitabine for cancer. Expert Opin Investig Drugs. 2012 Apr; 21(4):541-55. PMID: 22329458.
      Citations: 8     Fields:    Translation:HumansAnimals
    4. Guo L, Liu X, Jiang Y, Nishikawa K, Plunkett W. DNA-dependent protein kinase and ataxia telangiectasia mutated (ATM) promote cell survival in response to NK314, a topoisomerase IIa inhibitor. Mol Pharmacol. 2011 Aug; 80(2):321-7. PMID: 21546556.
      Citations: 6     Fields:    Translation:HumansCells
    5. Liu X, Wang Y, Benaissa S, Matsuda A, Kantarjian H, Estrov Z, Plunkett W. Homologous recombination as a resistance mechanism to replication-induced double-strand breaks caused by the antileukemia agent CNDAC. Blood. 2010 Sep 09; 116(10):1737-46. PMID: 20479284.
      Citations: 14     Fields:    Translation:HumansAnimalsCells
    6. Liu L, Akhter S, Bae JB, Mukhopadhyay SS, Richie CT, Liu X, Legerski R. SNM1B/Apollo interacts with astrin and is required for the prophase cell cycle checkpoint. Cell Cycle. 2009 Feb 15; 8(4):628-38. PMID: 19197158.
      Citations: 13     Translation:HumansAnimalsCells
    7. Wang Y, Liu X, Matsuda A, Plunkett W. Repair of 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine-induced DNA single-strand breaks by transcription-coupled nucleotide excision repair. Cancer Res. 2008 May 15; 68(10):3881-9. PMID: 18483273.
      Citations: 13     Fields:    Translation:HumansAnimalsCells
    8. Liu X, Matsuda A, Plunkett W. Ataxia-telangiectasia and Rad3-related and DNA-dependent protein kinase cooperate in G2 checkpoint activation by the DNA strand-breaking nucleoside analogue 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine. Mol Cancer Ther. 2008 Jan; 7(1):133-42. PMID: 18202016.
      Citations: 10     Translation:HumansCells
    9. Altunbas MC, Shaw CC, Chen L, Lai C, Liu X, Han T, Wang T. A post-reconstruction method to correct cupping artifacts in cone beam breast computed tomography. Med Phys. 2007 Jul; 34(7):3109-18. PMID: 17822018.
      Citations: 23     Fields:    Translation:Humans
    10. Guo L, Liu X, Nishikawa K, Plunkett W. Inhibition of topoisomerase IIalpha and G2 cell cycle arrest by NK314, a novel benzo[c]phenanthridine currently in clinical trials. Mol Cancer Ther. 2007 May; 6(5):1501-8. PMID: 17513599.
      Citations: 10     Translation:HumansCells
    11. Liu X, Guo Y, Li Y, Jiang Y, Chubb S, Azuma A, Huang P, Matsuda A, Hittelman W, Plunkett W. Molecular basis for G2 arrest induced by 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine and consequences of checkpoint abrogation. Cancer Res. 2005 Aug 01; 65(15):6874-81. PMID: 16061671.
      Citations: 13     Fields:    Translation:HumansCells
    12. He GA, Hou HM, Liu XJ. Naltrexone microspheres: in vitro release and effect on morphine analgesia in mice. Acta Pharmacol Sin. 2001 Jun; 22(6):530-3. PMID: 11747760.
      Citations: 2     Fields:    Translation:Animals
    13. Liu XJ, Wu WT. Effects of ligustrazine, tanshinone II A, ubiquinone, and idebenone on mouse water maze performance. Zhongguo Yao Li Xue Bao. 1999 Nov; 20(11):987-90. PMID: 11270979.
      Citations: 1     Fields:    Translation:Animals
    14. Oeltjen JC, Liu X, Lu J, Allen RC, Muzny D, Belmont JW, Gibbs RA. Sixty-nine kilobases of contiguous human genomic sequence containing the alpha-galactosidase A and Bruton's tyrosine kinase loci. Mamm Genome. 1995 May; 6(5):334-8. PMID: 7626884.
      Citations: 2     Fields:    Translation:HumansCells
    15. Cloning, sequencing and preliminary expression of human RP2 gene. Acta Biochimica et Biophysica Sinica. 32:199.
    16. Mechanism-based drug combinations with the DNA strand-breaking nucleoside analog CNDAC. Molecular Cancer Therapeutics. 15:2302-2313.
    17. ATM function and its relationship with ATM gene mutations in chronic lymphocytic leukemia with the recurrent deletion (11q22.3-23.2). Blood Cancer Journal. 6.
    LIU's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (128)
    Explore
    _
    Co-Authors (6)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _